Use of in situ simulation to evaluate the operational readiness of a high-consequence infectious disease intensive care unit
- PMID: 32221964
- DOI: 10.1111/anae.15048
Use of in situ simulation to evaluate the operational readiness of a high-consequence infectious disease intensive care unit
Abstract
On 30 January 2020, the World Health Organization (WHO) declared that the outbreak of a coronavirus disease-2019 (COVID-19) was a public health emergency of international concern. The WHO guidance states that patients with (COVID-19) should be managed by staff wearing appropriate personal protective equipment; however, working whilst wearing personal protective equipment is unfamiliar to many healthcare professionals. We ran high-fidelity, in-situ simulation of high-risk procedures on patients with COVID-19 in a negative-pressure side room on our intensive care unit (ICU). Our aim was to identify potential problems, test the robustness of our systems and inform modification of our standard operating procedures for any patients with COVID-19 admitted to our ICU. The simulations revealed several important latent risks and allowed us to put corrective measures in place before the admission of patients with COVID-19. We recommend that staff working in clinical areas expected to receive patients with COVID-19 conduct in-situ simulation in order to detect their own unique risks and aid in the creation of local guidelines of management of patients with COVID-19.
Keywords: COVID-19; coronavirus; intensive care medicine; simulation.
© 2020 Association of Anaesthetists.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention. Journal of the American Medical Association 2020; 2019: 3-6.
-
- WHO. Coronavirus disease 2019. World Health Organization 2020; 2019: 2633.
-
- Ghani AC, Donnelly CA, Cox DR, et al. Methods for estimating the case fatality ratio for a novel, emerging infectious disease. American Journal of Epidemiology 2005; 162: 479-86.
-
- Xuanyue M, Yanli N, Hao C, Pengli J, Mingming Z. Literature review regarding patient safety culture. Journal of Evidence-Based Medicine 2013; 6: 43-9.
-
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
